Unique ID issued by UMIN | UMIN000054062 |
---|---|
Receipt number | R000061723 |
Scientific Title | Quantification of radiation pneumonitis and Prediction of Respiratory Function Changes Using 4D-CT and Respiratory Function Testing |
Date of disclosure of the study information | 2024/04/04 |
Last modified on | 2024/04/04 15:50:55 |
Quantification of radiation pneumonitis and Prediction of Respiratory Function Changes Using 4D-CT and Respiratory Function Testing
Quantification of radiation pneumonitis and Prediction of Respiratory Function Changes Using 4D-CT and Respiratory Function Testing
Quantification of radiation pneumonitis and Prediction of Respiratory Function Changes Using 4D-CT and Respiratory Function Testing
Quantification of radiation pneumonitis and Prediction of Respiratory Function Changes Using 4D-CT and Respiratory Function Testing
Japan |
malignant thoracic tumor
Radiology |
Malignancy
NO
1) Quantify radiation pneumonitis using the rate of change obtained from respiratory function test data before and after radiotherapy.
2) To predict post-treatment respiratory function changes in radiotherapy patients by analyzing pre- and post-treatment respiratory function changes, lung function images obtained from 4D-CT, and pulmonary DVH parameters.
Others
1) Quantify radiation pneumonitis using the rate of change obtained from respiratory function test data before and after radiotherapy.
2) To predict post-treatment respiratory function changes in radiotherapy patients by analyzing pre- and post-treatment respiratory function changes, lung function images obtained from 4D-CT, and pulmonary DVH parameters.
Exploratory
Others
Not applicable
1) Quantification of radiation pneumonitis
2) Prediction of post-treatment respiratory function changes in radiotherapy patients
1) Prediction of radiation pneumonitis range
2) Correlation between pulmonary function images obtained from 4D-CT images and respiratory function tests
3) Influence of drugs used in combination with radiotherapy on respiratory function
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients must be at least 20 years of age and have histologically proven malignancy.
2) Patients with no previous radiation therapy to the chest.
3) Patients who are scheduled to undergo radical radiotherapy for lung cancer with a total dose of 40 Gy or more.
1) Patients with active interstitial pneumonia requiring treatment.
2) Patients with serious complications (liver cirrhosis, diabetes, cardiac disease, etc.).
3) Pregnant and lactating women.
100
1st name | Tomohiro |
Middle name | |
Last name | Itonaga |
Tokyo Medical University
Department of Radiology
160-0023
6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo
03-3342-6111
itonaga@tokyo-med.ac.jp
1st name | Tomohiro |
Middle name | |
Last name | Itonaga |
Tokyo Medical University
Department of Radiology
160-0023
6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo
03-3342-6111
itonaga@tokyo-med.ac.jp
Tokyo Medical University
Japan Science and Technology Agency
Japanese Governmental office
The ethical committee of Tokyo Medical University
6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo
03-3342-6111
Sys_IRB@tokyo-med.ac.jp
NO
東京医科大学病院
2024 | Year | 04 | Month | 04 | Day |
Unpublished
Open public recruiting
2023 | Year | 08 | Month | 25 | Day |
2023 | Year | 08 | Month | 25 | Day |
2023 | Year | 08 | Month | 25 | Day |
2025 | Year | 03 | Month | 31 | Day |
IRB number:T2023-0095
2024 | Year | 04 | Month | 04 | Day |
2024 | Year | 04 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061723